Amarin Reports Third Quarter 2023 Financial Results

-- Company Reported Total Net Revenues of $66 Million in the Third Quarter 2023 -- -- Delivered Positive Cash Flow of $8 Million in the Quarter, M...

Related Keywords

South Korea ,Dublin ,Ireland ,New Jersey ,United States ,Switzerland ,United Kingdom ,France ,Israel ,China ,Germany ,Netherlands ,Spain ,Canada ,Italy ,Spanish ,German ,Dutch ,Italian ,Mark Marmur ,Patrick Holt ,Scottish Medicines Consortium ,Company Reported Total Net Revenues ,Lotus Pharmaceuticals ,Exchange Commission Regulation ,Company To Host Conference Call ,Health Technology Assessment ,National Medical Products Administration ,Nasdaq ,Amarin Corporation ,Dutch Ministry Of Health ,Exchange Commission ,Spanish Drug Pricing Committee ,Reported Total Net Revenues ,Third Quarter ,Positive Cash Flow ,Marking Fifth Consecutive Quarter ,Cash Positive ,Quarter Ending Cash Position ,Through Extended Lifecycle ,Market Leadership ,Launch Progress ,European Countries Driven ,Host Conference Call Today ,Dutch Ministry ,Edding Pharm ,Southeast Asia ,Middle East ,Organizational Restructuring Plan ,Financial Information ,Securities Act ,Term Liabilities ,